Stay updated on TAA-Specific CTLs in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the TAA-Specific CTLs in Lymphoma Clinical Trial page.

Latest updates to the TAA-Specific CTLs in Lymphoma Clinical Trial page
- Check4 days agoChange DetectedThe history now shows a new revision entry v3.3.4 added and the previous v3.3.3 removed. There are no changes to core content, study data, or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a new Revision: v3.3.3 entry to the record history and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision tag v3.3.2 appears, replacing the previous v3.2.0, on the page; this is a minor metadata update with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the standard notice about potential data delays and operating status guidance (links to cc.nih.gov and opm.gov).SummaryDifference0.5%

- Check75 days agoChange DetectedNew version entry added on 2025-06-03 with updates to Study Status and Recruitment Status in the record history.SummaryDifference0.1%

- Check104 days agoChange DetectedAdded a government-operating status notice and updated version to v3.2.0; removed the old v3.1.0 reference. The page now communicates current operating status and versioning.SummaryDifference10%

Stay in the know with updates to TAA-Specific CTLs in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAA-Specific CTLs in Lymphoma Clinical Trial page.